BDNF augmentation reverses cranial radiation therapy-induced cognitive decline and neurodegenerative consequences
2024

Riluzole Improves Cognitive Function After Cranial Radiation Therapy

Sample size: 45 publication 10 minutes Evidence: high

Author Information

Author(s): El-Khatib Sanad M., Vagadia Arya R., Le Anh C. D., Baulch Janet E., Ng Ding Quan, Du Mingyu, Johnston Kevin G., Tan Zhiqun, Xu Xiangmin, Chan Alexandre

Primary Institution: University of California, Irvine

Hypothesis

Enhancing levels of brain-derived neurotrophic factor (BDNF) in the irradiated brain will improve cognitive function.

Conclusion

Oral administration of riluzole significantly improved cognitive function and reduced neuroinflammation in mice subjected to cranial radiation therapy.

Supporting Evidence

  • Riluzole treatment significantly increased hippocampal BDNF levels in irradiated mice.
  • Irradiated mice receiving RZ showed improved performance in cognitive tasks compared to those receiving vehicle.
  • RZ treatment reduced neuroinflammation in the irradiated brain.
  • Spatial transcriptomics revealed upregulation of neuroprotective genes in RZ-treated mice.
  • RZ administration preserved synaptic integrity in the hippocampus.

Takeaway

Giving a medicine called riluzole to mice that had brain radiation helped them think better and reduced brain swelling.

Methodology

Mice were given cranial radiation and then treated with riluzole for 6-7 weeks, followed by cognitive function tests and brain analysis.

Potential Biases

Potential bias in animal selection and treatment administration.

Limitations

The study was conducted on mice, and results may not directly translate to humans.

Participant Demographics

Adult male wild-type mice (C57BL/6), aged 12-13 weeks.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s40478-024-01906-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication